| 000 | 01463 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513003356.0 | ||
| 264 | 0 | _c19810224 | |
| 008 | 198102s 0 0 eng d | ||
| 022 | _a0300-7995 | ||
| 024 | 7 |
_a10.1185/03007998009112034 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCrisp, A J | |
| 245 | 0 | 0 |
_aLipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study. _h[electronic resource] |
| 260 |
_bCurrent medical research and opinion _c1980 |
||
| 300 |
_a101-3 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclopenthiazide _xtherapeutic use |
| 650 | 0 | 4 | _aDiuretics |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xblood |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 |
_aLipoproteins _xblood |
| 650 | 0 | 4 |
_aLipoproteins, HDL _xblood |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xblood |
| 650 | 0 | 4 |
_aOxprenolol _xtherapeutic use |
| 650 | 0 | 4 |
_aSodium Chloride Symporter Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aKennedy, P G | |
| 700 | 1 | _aHoffbrand, B I | |
| 700 | 1 | _aEbbutt, A F | |
| 700 | 1 | _aCarruthers, M | |
| 773 | 0 |
_tCurrent medical research and opinion _gvol. 7 _gno. 2 _gp. 101-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1185/03007998009112034 _zAvailable from publisher's website |
| 999 |
_c7002142 _d7002142 |
||